Burning Questions for the Top Orthopedic Players in 2024

In 2024, more than 60% of all orthopedic sales are generated by just six public companies, each with over $2 billion in annual sales.

But each of those companies is facing significant questions or tests this year. Below we dive into one of these questions for each of Stryker, DePuy Synthes, Zimmer Biomet, Smith+Nephew, Medtronic and Globus...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us